tiprankstipranks
LENZ Therapeutics (LENZ)
NASDAQ:LENZ
US Market

LENZ Therapeutics (LENZ) Income Statement

Compare
166 Followers

LENZ Therapeutics Income Statement

Last quarter (Q3 2024), LENZ Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, LENZ Therapeutics's net income was $-10.21M. See LENZ Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 15.00M$ 0.00$ 0.00$ 0.00
Gross Profit
$ -2.41M$ 6.65M$ -734.00K$ -121.00K$ 0.00
Operating Expenses
$ 70.70M$ 97.29M$ 59.71M$ 13.38M$ 29.00K
Depreciation and Amortization
$ 2.41M$ 8.35M$ 734.00K$ 121.00K$ 171.86K
EBITDA
$ -122.24M$ -97.29M$ -70.03M$ -68.21M$ -29.00K
Operating Income
$ -73.11M$ -105.64M$ -60.44M$ -13.50M$ -29.00K
Other Income/Expenses
$ -51.54M$ 4.59M$ -10.32M$ -54.87M$ -80.00K
Pretax Income
$ -124.65M$ -101.05M$ -70.76M$ -68.37M$ -109.00K
Net Income
$ -124.65M$ -101.05M$ -70.76M$ -68.37M$ -109.00K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -15.30$ -12.89$ -8.54$ -8.24$ -0.01
Diluted EPS
$ -15.30$ -12.89$ -8.54$ -8.24$ -0.01
Weighted Average Shares Outstanding
8.15M 7.84M 8.29M 8.30M 8.30M
Weighted Average Shares Outstanding (Diluted)
8.15M 7.84M 8.29M 8.30M 8.30M
Currency in USD

LENZ Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis